Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with INSM: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
INSM
Insmed Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
INSM
Insmed Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
INSM: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only INSM
13
AZN
AstraZeneca
supplier
—
Bridgewater Biotech Center LLC (assumed from Exeter 700 Route 202/206, LLC)
unlisted
supplier
—
Esteve Química, S.A. (Esteve)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
PARI Pharma GmbH (PARI)
unlisted
supplier
9 more · INSM chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
INSM, dashed
LLY
ELI Lilly & Co
Change
1,412.87
▲
+2.85%
· post 1,417.05
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
INSM
Insmed Inc
Change
112.61
▲
+0.91%
· post 112.65
Closed
Oct 30 '26
Mkt cap
$24.7B
Revenue
$524M
Q3 FY26
Revenue
$606M
FY25
vs
Compare
Closed
Oct 30 '26
LLY
ELI Lilly & Co
vs
INSM
Insmed Inc
1,412.87
▲
+2.85%
post 1,417.05
Price
112.61
▲
+0.91%
post 112.65
$1.3T
Mkt cap
$24.7B
Q3 FY26
$24.4B
Revenue
$524M
Q3 FY26
FY25
$65.2B
Revenue
$606M
FY25
Change
Change
LLY
1,412.87
▲
+2.85%
vs
INSM
112.61
▲
+0.91%
Closed
Oct 30 '26